XNAS
BACK
Market cap198kUSD
Apr 04, Last price
0.06USD
1D
43.66%
1Q
-95.82%
IPO
-99.81%
Name
IMAC Holdings Inc
Chart & Performance
P/E
—
P/S
0.04
EPS
—
Div Yield, %
—
Shrs. gr., 5y
35.72%
Rev. gr., 5y
-4.96%
Revenues
5m
-67.89%
Net income
-9m
L-64.78%
CFO
-3m
L-72.90%
Earnings
May 05, 2025
Profile
IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | 5,197 -67.89% | 16,186 12.51% | ||||||
Cost of revenue | 1,356 | 24,408 | ||||||
Unusual Expense (Income) | ||||||||
NOPBT | 3,841 | (8,222) | ||||||
NOPBT Margin | 73.91% | |||||||
Operating Taxes | 8,432 | |||||||
Tax Rate | ||||||||
NOPAT | 3,841 | (16,654) | ||||||
Net income | (9,419) -64.78% | (26,745) 140.86% | ||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | 17 | 4,472 | ||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | 1,440 | |||||||
Long-term debt | 6,768 | |||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | (222) | 7,444 | ||||||
| Cash flow | ||||||||
Cash from operating activities | (2,790) | (10,294) | ||||||
CAPEX | (331) | |||||||
Cash from investing activities | (1,775) | (260) | ||||||
Cash from financing activities | 4,024 | 4,199 | ||||||
FCF | 10,210 | (15,760) | ||||||
| Balance | ||||||||
Cash | 222 | 763 | ||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | (55,937) | (46,487) | ||||||
Invested Capital | 55,185 | 55,294 | ||||||
ROIC | 6.95% | |||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | 1,112 | 942 | ||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | 4,244 | (6,595) | ||||||
EV/EBITDA | ||||||||
Interest | 14 | |||||||
Interest/NOPBT | ||||||||